Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Multiple Myeloma 2Depression 2Breast Neoplasms 2Anxiety Disorders 2Uveal Melanoma 1Small Cell Lung Carcinoma 1Prolactin-Producing Pituitary Tumor 1Pituitary ACTH Hypersecretion 1Neoplasms 1Neoplasm Metastasis 1Metastatic Solid Tumor Cancers 1Lung Neoplasms 1Glioma 1Glioblastoma 1Cushing Syndrome 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Cancer Caregivers 1

Interventions

relacorilant 6Mifepristone 4Osilodrostat 3Corlux 3Metyrapone 2Adrenalectomy 2pembrolizumab 1Perceived Stress Scale 1Observation 1Dabigatran 1Continuous Glucose Monitoring 1Abiraterone Acetate 1ASP3662 14-amino-4'-hydroxylaminodiphenylsulfone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cushing Syndrome × 4-amino-4'-hydroxylaminodiphenylsulfone × Clear all
NCT03364803 2025-10-23

Collecting Information About Treatment Results for Patients With Cushing's Syndrome

Memorial Sloan Kettering Cancer Center

Recruiting
300 enrolled
Endocrine

Cushing Syndrome, Pituitary ACTH Hypersecretion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡